The Prostate Cancer Dilemma Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy /

This comprehensive text provides a complete description of the newest technologies to diagnose and manage the most common prostate cancer diagnosed today: low risk disease. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologie...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Stone, Nelson N. (Επιμελητής έκδοσης), Crawford, E. David (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2016.
Έκδοση:1st ed. 2016.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Part One: Diagnosis
  • History of PSA, from Detection to Over Diagnosis
  • Pathology of Prostate Cancer: What has Changed in the Last 30 years?- Clinical Risk Prediction Tools for Prostate Cancer: TMN to CAPRA-Should Risk be Re-defined?- TRUS Biopsy: Is There Still a Role?- Transperineal Biopsy Technique
  • 3D Biopsy: A New Method to Diagnose Prostate Cancer
  • Elastography: Can it Improve Prostate Biopsy Results?- Multi parametric MRI of the Prostate as a Tool for Prostate Cancer Detection
  • Genomic Markers
  • Part Two: Treatment
  • Current Status of Clinical Trials in Active Surveillance
  • Focused targeted Therapy in Prostate Cancer
  • Technologies and Methods in Primary Ablation with Focal Therapy
  • Multi parametric MRI (mpMRI)-Guided Focal Therapy
  • Conclusions.